Altus Pharmaceuticals Inc. (NASDAQ: ALTU), announced today that Georges Gemayel, Ph.D., President and CEO of Altus, will present at the Collins Stewart Fourth Annual Growth Conference on July 9, 2008 at 4:30 pm ET in New York City.
A webcast of this event will be available to all interested parties on the Altus Pharmaceuticals investor relations website at http://ir.altus.com/events.cfm. An archived version of the webcast will be available later that day on the Altus investor relations website in the Events and Presentations section.
About Altus Pharmaceuticals Inc.
Altus Pharmaceuticals, headquartered in Cambridge, MA, is a biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders. The Company's website is http://www.altus.com.
Altus Pharmaceuticals Inc.
John A. Jordan, 617-299-2852
Senior
Director, Corporate Communications